Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
Ilham Aliyev meets Mauritian PresidentChina Floods: 10 DeadOppenheimer Reiterates Outperform on UroGen PharmaAzərenerji: Electricity demand to rise 4 GW in 5 yearsGuggenheim Upgrades StubHub Stock on ResetCanaan Earnings Miss Estimates by $0.83Poverty drops from 49% to 5% in AzerbaijanIron Mountain SWOT analysis: stock draws optimismAraghchi Accuses US of Breaking PromisesIOC Q4 2026 earnings beat expectationsIlham Aliyev meets Mauritian PresidentChina Floods: 10 DeadOppenheimer Reiterates Outperform on UroGen PharmaAzərenerji: Electricity demand to rise 4 GW in 5 yearsGuggenheim Upgrades StubHub Stock on ResetCanaan Earnings Miss Estimates by $0.83Poverty drops from 49% to 5% in AzerbaijanIron Mountain SWOT analysis: stock draws optimismAraghchi Accuses US of Breaking PromisesIOC Q4 2026 earnings beat expectations
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU
COMPANY

Evoke Extends Bally’s Intralot Bid Deadline

Evoke extends Bally’s Intralot takeover offer deadline. Details on Bond.az.

James Taylor
ByJames Taylor- Senior Editor
|
0
Evoke Extends Bally’s Intralot Bid Deadline
Photo: Prepared by Bond.az

Bond.az reports that Evoke plc has extended the deadline for Bally’s Intralot S.A. to announce a firm takeover offer.

The initial announcement was made on April 20, 2026, with a proposed offer of 50 pence per share.

Bally’s Intralot requested an extension, which the Evoke board granted. The new deadline is June 8, 2026, at 5:00 p.m. London time.

Discussions continue, with the proposal expected to be an all-share combination with a partial cash alternative.

There is no certainty that a firm offer will be made.

More News
Ocado Admits 62,729 Shares to London Stock Exchange
Today / 07:43
|
570

Ocado Admits 62,729 Shares to London Stock Exchange

Ocado Group plc admits 62,729 ordinary shares to trading on the London Stock Exchange under the Restricted Share Plan.

COMPANY →
0
Avacta reports 2025 results, raises £32.5m for oncology trials
Today / 07:04
|
876

Avacta reports 2025 results, raises £32.5m for oncology trials

Avacta Group reports 2025 preliminary results, raises £32.5 million for oncology trials. Updates on AVA6103 and AVA6000 programs.

COMPANY →
0
Greatland Issues Shares for Employee Incentive Plan
Today / 07:02
|
489

Greatland Issues Shares for Employee Incentive Plan

Greatland Resources issues 1.76 million shares for employee incentive plan at A$14.11 each. Shares to be admitted to AIM trading.

COMPANY →
0
Kidney Transplant Rejection Test Study Published
Today / 06:46
|
626

Kidney Transplant Rejection Test Study Published

Verici Dx's study on kidney transplant rejection test published in Kidney360. PTRA test predicts early acute rejection better than traditional tools.

COMPANY →
0
Power Metallic forms Saudi joint venture with Amaar Mining
Today / 06:45
|
717

Power Metallic forms Saudi joint venture with Amaar Mining

Power Metallic and Amaar Mining form 50/50 joint venture in Saudi Arabia. Initial funding of $10 million.

COMPANY →
0
Bayer's asundexian gets FDA priority review
Today / 06:43
|
917

Bayer's asundexian gets FDA priority review

FDA grants Priority Review to Bayer's asundexian for secondary stroke prevention. Phase III trial results show promise.

COMPANY →
0
Orosur Mining Issues 2.85M Shares After RSU Exercise
Today / 06:33
|
784

Orosur Mining Issues 2.85M Shares After RSU Exercise

Orosur Mining issues 2.85M shares after directors and consultants exercise RSUs. Shares to trade on AIM from May 22, 2026.

COMPANY →
0
Golden Prospect Moves Portfolio Management to Manulife
Today / 06:31
|
966

Golden Prospect Moves Portfolio Management to Manulife

Golden Prospect Precious Metals delegates portfolio management to Manulife. New managers Diana Racanelli and Craig Bethune appointed.

COMPANY →
0
SSP Group Appoints Candace McGraw to Board
Today / 06:22
|
948

SSP Group Appoints Candace McGraw to Board

SSP Group appoints Candace McGraw as independent non-executive director. Effective June 1, she brings aviation expertise.

COMPANY →
0
CBL-514: New Obesity Data Revealed
Today / 06:01
|
902

CBL-514: New Obesity Data Revealed

Caliway Biopharmaceuticals reveals new data on CBL-514 for obesity. Combination therapy boosts weight loss by 91.5%.

COMPANY →
0
Genentech to Present Breast Cancer Data at ASCO Meeting
Today / 05:21
|
881

Genentech to Present Breast Cancer Data at ASCO Meeting

Genentech will present breast cancer data on giredestrant and other drugs at the 2026 ASCO meeting.

COMPANY →
0
Onto Innovation prices $1.3B convertible notes
Today / 03:43
|
453

Onto Innovation prices $1.3B convertible notes

Onto Innovation prices $1.3 billion convertible senior notes due 2031 at a 50% conversion premium. Interest-free notes with strong liquidity.

COMPANY →
0
...